Fricke, W <br/><br/>
FDA perspective on and response to the risk of hepatitis A from blood products.  [electronic resource] 

 -  Vox sanguinis  1994 
 - 16-8; discussion 24-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0042-9007 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blood Coagulation Factors--adverse effects<br/>Databases, Factual<br/>Detergents<br/>Disease Outbreaks<br/>Drug Contamination<br/>Europe--epidemiology<br/>Hepatitis A--epidemiology<br/>Humans<br/>Parvoviridae Infections--epidemiology<br/>Risk<br/>Safety<br/>Solvents<br/>United States--epidemiology<br/>United States Food and Drug Administration